ERC-2018-PoC
ERC-2018-PoC
Programme: H2020
160 projects · €23,921,092 total EU contribution (project-level) · 125 participating organizations · 20 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€23,921,092
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (17)
- UK (17)
- Spain (16)
- Germany (14)
- Netherlands (13)
- France (10)
- AT (6)
- CH (6)
- FI (4)
- IL (4)
- BE (3)
- IE (3)
- PT (3)
- SE (2)
- SK (2)
- BG (1)
- CY (1)
- DK (1)
- HR (1)
- NO (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- WEIZMANN8 projects · IL
- UOXF7 projects · UK
- CNRS5 projects · FR
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY5 projects · IL
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5 projects · UK
- CNRS INNOVATION4 projects · FR
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4 projects · UK
- POLIMI4 projects · IT
- IIT3 projects · IT
- IRB BARCELONA - CERCA3 projects · ES
- IBM3 projects · CH
- UNIVERSITY COLLEGE LONDON3 projects · UK
Projects
Page 13 of 16
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer TAcTIC · 839325 | H2020 | €150,000 | €21,250 | Details |
IMPLEMENTATION OF A SUSTAINABLE AND COMPETITIVE SYSTEM TO SIMULTANEOUSLY PRODUCE ASTAXANTHIN AND OMEGA-3 FATTY ACIDS IN MICROALGAE FOR ACQUACULTURE AND HUMAN NUTRITION ASTAOMEGA · 825936 | H2020 | €149,955 | €149,995 | Details |
Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases EPI-X4Health · 813081 | H2020 | €149,156 | €26,950 | Details |
Development of Collagenase Polymeric nanocapsules as Therapeutics DECOMPACT · 825435 | H2020 | €149,611 | €149,611 | Details |
Implementation of ACT in Daily Life IMPACT · 842501 | H2020 | €149,688 | €149,688 | Details |
Crosspoint In-memoRy CompUting Systems CIRCUS · 842472 | H2020 | €149,464 | €149,464 | Details |
a rapid and efficient method for generation of iPSC EASY-IPS · 825942 | H2020 | €150,000 | €150,000 | Details |
A Technology for the Generation of Stable Enzymes INCYPRO · 839088 | H2020 | €150,000 | €150,000 | Details |
Metabolic Profiling of the Vaginal Microbiome for Reproductive Health MUMVIP · 825813 | H2020 | €149,633 | €149,633 | Details |
Enhancing biological drug production through protein secretion SECReTE · 825761 | H2020 | €150,000 | €150,000 | Details |